Genetic determinants of severity and recurrence in arrhythmia-induced cardiomyopathy
European Journal of Heart Failure · 25.05.2026
DOI: 10.1093/ejhf/xuag181 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 25.05.2026. Verfasst von Coloma Tiron und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitari Dr. Josep Trueta, Girona, Spain. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Union, Obra Social ‘La Caixa Foundation’.
Abstract (Originalsprache)
Aims
Arrhythmia-induced cardiomyopathy develops unpredictably in a subset of patients with atrial fibrillation, with marked interindividual variability in severity and recurrence risk. Whether genetic susceptibility contributes to this heterogeneity remains uncertain. We aimed to determine the prevalence and clinical impact of deleterious variants in cardiomyopathy-associated genes among patients with arrhythmia-induced cardiomyopathy.
Methods
In this retrospective, multicentre study, patients with arrhythmia-induced cardiomyopathy underwent genetic testing targeting cardiomyopathy-associated genes. Individuals carrying pathogenic or likely pathogenic variants were classified as genotype-positive. Baseline characteristics, clinical severity and follow-up outcomes were compared between genotype-positive and genotype-negative patients.
Results
In 100 patients (mean age 59.9 ± 11.1 years, 18% women, baseline left ventricular ejection fraction 28.2 ± 7.3%), 16 (16%) were genotype-positive, with TTN truncating variants accounting for 75% of variants. Compared with genotype-negative individuals, genotype-positive patients more frequently had a family history of cardiomyopathy (31.2% vs 4.8%, P = .005) and sudden death (25% vs 6%, P = .034), presented with more severe disease -including lower ejection fraction (24.6% vs 28.8%, P = .034) and higher incidence of cardiogenic shock (25% vs 3.6%, P = .012)- and exhibited a higher risk of recurrence (18.8% vs 2.4%, P = .028).
Conclusions
Arrhythmia-induced cardiomyopathy patients exhibit a substantial prevalence of deleterious variants in cardiomyopathy-associated genes, particularly TTN truncating variants. Genotype-positive individuals represent a high-risk subgroup with greater familial burden, more severe clinical presentation and increased recurrence risk. Genetic testing may identify at-risk patients, refine prognostic stratification and guide therapy and follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hospital Universitari Dr. Josep Trueta, Girona, Spain.
- Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
- Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR Sant Pau), Universitat Autònoma de Barcelona, Spain.
- Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain.
- BioHeart Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
ORCID-Profile: Coloma Tiron, Jose M Guerra, Fernando de Frutos
Förderung
- Instituto de Salud Carlos III
- European Union
- Obra Social ‘La Caixa Foundation’
- Fondo de Investigación Sanitaria FIS
- Instituto Salud Carlos III
Zitieren
APA
Tiron, C., Soriano-Amores, M., Ramos-Polo, R., Solé-González, E., Loma-Osorio, P., Fernández-Falgueras, A., Coll, M., Fort, A., Fluvià, P., Jordà, P., Moliner-Abós, C., Casadevall, A., Llongueras-Espi, P., Guerra, J. M., Mirabet-Pérez, S., de Antonio-Ferrer, M., Morillas, H., de Frutos, F., Rivera, A. M., …, & Brugada, R. (2026). Genetic determinants of severity and recurrence in arrhythmia-induced cardiomyopathy. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag181
Vancouver
Tiron C, Soriano-Amores M, Ramos-Polo R, Solé-González E, Loma-Osorio P, Fernández-Falgueras A, et al. Genetic determinants of severity and recurrence in arrhythmia-induced cardiomyopathy. European Journal of Heart Failure. 2026. doi:10.1093/ejhf/xuag181
BibTeX
@article{Tiron2026,
author = {Tiron, Coloma and Soriano-Amores, Marc and Ramos-Polo, Raúl and Solé-González, Eduard and Loma-Osorio, Pablo and Fernández-Falgueras, Anna and Coll, Mònica and Fort, Aleix and Fluvià, Paula and Jordà, Paloma and Moliner-Abós, Carlos and Casadevall, Astrid and Llongueras-Espi, Pasqual and Guerra, Jose M and Mirabet-Pérez, Sònia and de Antonio-Ferrer, Marta and Morillas, Herminio and de Frutos, Fernando and Rivera, Anna Moles and Campuzano, Oscar and Brugada, Ramon},
title = {Genetic determinants of severity and recurrence in arrhythmia-induced cardiomyopathy},
journal = {European Journal of Heart Failure},
year = {2026},
doi = {10.1093/ejhf/xuag181}
}
EUVIMED